BAGE3 Polyclonal Antibody

BAGE3, also named as CT2.2, belongs to the BAGE family. BAGE3 is a candidate gene encoding tumor antigens. It is cancer/testis antigen 2. The antibody can recognize BAGE2 and BAGE3.

The AZI1 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of AZI1 protein expression in various biological samples. This antibody is produced using state-of-the-art techniques, ensuring high affinity and specificity towards AZI1.

AZI1, also known as 5-azacytidine-induced protein 1, is a crucial protein involved in diverse cellular processes, including cell cycle regulation, DNA repair, and apoptosis. Its dysregulation has been implicated in various diseases, making it an important target for research and diagnostic purposes.

The AZI1 Polyclonal Antibody exhibits exceptional performance in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It recognizes endogenous levels of AZI1 protein, enabling accurate quantification and localization studies.

With its superior sensitivity and specificity, this antibody provides researchers with reliable and reproducible results, facilitating a deeper understanding of AZI1's role in cellular processes and disease pathogenesis. Its versatility and robustness make it an invaluable tool for both basic research and clinical applications.

The AZI1 Polyclonal Antibody is supplied in a convenient and ready-to-use format, ensuring ease of use and minimizing experimental variability. It is available in different sizes to accommodate various experimental needs. Each batch is rigorously quality tested to ensure consistent performance and reliability.

In summary, the AZI1 Polyclonal Antibody is a highly reliable and specific tool for the detection and analysis of AZI1 protein expression. Its exceptional performance in various applications, combined with its convenience and reliability, makes it an essential asset for researchers and clinicians alike.